Inventor · disambiguated record
Dennie S. Welch
Also filed as: WELCH DENNIE · WELCH DENNIE S
10 granted patents·11 pending applications·23 citations·filing 2010–2024
83Inventor score
Files withABBVIE INC11ABBVIE DEUTSCHLAND2AKRITOPOULOU-ZANZE IRINI2ACKLER SCOTT L1CALICO LIFE SCIENCES LLC1
Top patents by PatentIndex Score
21 records- 0193US9809576B1Synthetic route to anti-viral agentsABBVIE INC·Filed 2015·Granted Nov 7, 2017·14 cites·2 claims
- 0286US10077256B2Synthetic route to anti-viral agentsABBVIE INC·Filed 2017·Granted Sep 18, 2018·2 cites·14 claims
- 0384US2025177374A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2024·Application pending·0 cites
- 0483US10954202B2Protein tyrosine phosphatase inhibitors and methods of use thereofCALICO LIFE SCIENCES LLC·Filed 2020·Granted Mar 23, 2021·1 cites·4 claims
- 0577US2024058450A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2022·Application pending·0 cites
- 0673US2020246460A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 0773US2020095230A1Synthetic route to anti-viral agentsABBVIE INC·Filed 2019·Application pending·0 cites
- 0872US9096550B2Bryostatin analogues and methods of making and using thereofKECK GARY E·Filed 2010·Granted Aug 4, 2015·6 cites·35 claims
- 0970US10442792B2Synthetic route to anti-viral agentsABBVIE INC·Filed 2018·Granted Oct 15, 2019·0 cites·30 claims
- 1064US2020239553A1BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 1162US2019142941A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 1253US2016339117A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2015·Application pending·0 cites
- 1353US2018346484A1Modulators of 5-ht receptors and methods of use thereofABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1452US9493506B2Macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2014·Granted Nov 15, 2016·0 cites·21 claims
- 1547US9879033B2Modulators of 5-HT receptors and methods of use thereofABBVIE DEUTSCHLAND·Filed 2015·Granted Jan 30, 2018·0 cites·9 claims
- 1645US9187483B2Modulators of 5-HT receptors and methods of use thereofAKRITOPOULOU-ZANZE IRINI·Filed 2010·Granted Nov 17, 2015·0 cites·13 claims
- 1742US2017182179A1Antibody Drug Conjugates with Cell Permeable BCL-XL InhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 1842US2016158377A1BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the SameACKLER SCOTT L·Filed 2015·Application pending·0 cites
- 1938US8748374B2Macrocyclic hepatitis C serine protease inhibitorsCHEN HUI-JU·Filed 2011·Granted Jun 10, 2014·0 cites·20 claims
- 2035US2017239212A1Bryostatin analogs and use thereof as antiviral agentsUNIV UTAH RES FOUND·Filed 2015·Application pending·0 cites
- 2133US8846951B2Modulators of 5-HT receptors and methods of use thereofAKRITOPOULOU-ZANZE IRINI·Filed 2010·Granted Sep 30, 2014·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →